Optimization of peptide-based polyagonists for treatment of diabetes and obesity

Bioorg Med Chem. 2018 Jun 1;26(10):2873-2881. doi: 10.1016/j.bmc.2017.10.047. Epub 2017 Nov 2.

¹ Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
² Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
³ Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, 80333 Munich, Germany.
⁴ Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA; Department of Chemistry, Indiana University, Bloomington, IN, USA. Electronic address: rdimarch@indiana.edu.

No abstract available

Publication types